Scientific Publications

Intratracheal administration: Non-invasive approach for livertargeted siRNA-LNP delivery

RNA interference therapy targeting coagulation factor XI - a first-in-human trial of RBD4059

Intratracheal administration: Non-invasive approach for liver-targeted siRNA-LNP delivery

A Potent GalNAc-siRNA Drug, RBD1016, Leads to Sustained HBsAg Reduction and Seroconversion in Mouse Models of HBV infection

Prediction of Interspecies Translation for Targeting Delivery Coefficients of GalNAc-siRNA Silencing Apolipoprotein C-III Using a Mechanistic Minimal Physiologically Based Pharmacokinetic/Pharmacodynamic Model

Inhibition of Factor XI Using RBD4059: A Novel GalNAc-siRNA With Potent and Durable Antithrombotic Effects